Evidence map›Paper›PMID 33785614›Full record

ArticlemBio2021

The DnaK Chaperone System Buffers the Fitness Cost of Antibiotic Resistance Mutations in Mycobacteria.

Allison Fay, John Philip, Priya Saha, Ronald C Hendrickson, Michael S Glickman, Kristin Burns-Huang

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. A Small Molecule Substrate Mimic to Inhibit Bacterial Hsp70 Chaperone Function.Chembiochem : a European journal of chemical biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Proteostasis-targeted antibacterial strategies.Journal of microbiology (Seoul, Korea) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Selection of Multi-Drug Targets against Drug-ResistantInternational journal of molecular sciences · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genomic and Transcriptomic Analysis of BovineFrontiers in veterinary science · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Allison FayImmunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA faya@mskcc.org krb2013@med.cornell.edu.
John PhilipMicrochemistry and Proteomics Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Priya SahaDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, USA.
Ronald C HendricksonMicrochemistry and Proteomics Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Michael S GlickmanImmunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0001-7918-5164
Kristin Burns-HuangDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, USA faya@mskcc.org krb2013@med.cornell.edu.ORCID 0000-0002-8202-3884
Memorial Sloan Kettering Cancer Center · USCornell University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Viable but Nonculturable MtbU19AI111143 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI FITZGERALD, DANIEL W, GLICKMAN, MICHAEL S · 2014 to 2020
$48.6M
NCI NIH HHS P30 CA008748NIAID NIH HHS U19 AI111143
6 · The paper itself

Abstract

Chaperones aid in protein folding and maintenance of protein integrity. In doing so, they have the unique ability to directly stabilize resistance-conferring amino acid substitutions in drug targets and to counter the stress imparted by these substitutions, thus supporting heritable antimicrobial resistance (AMR). We asked whether chaperones support AMR in

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsBacterial ProteinsDNA-Directed RNA PolymerasesHumansMolecular ChaperonesMutationMycobacterium smegmatisMycobacterium tuberculosisProtein BindingTuberculosisAnti-Bacterial AgentsBacterial ProteinsDNA-Directed RNA PolymerasesDnaK protein, Mycobacterium smegmatisMolecular Chaperonesantimicrobial resistanceDnaKmycobacteriaprotein chaperone

Identifiers

PMID33785614
PMCPMC8092207
OpenAlexW3141847343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.